13720

    532771

    JHS

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    JHS SVEND. LAB. LTD Share Price Today

    JHS SVEND. LAB. LTD is currently trading at ₹7.64, up by ₹0.06 from the previous close. The stock touched an intraday high of ₹7.86 and a low of ₹7.31 during the latest trading session. Over the past one year, JHS SVEND. LAB. LTD has delivered a loss of 39.0%, while the stock has gained 1.33% in the last one month.

    JHS SVEND. LAB. LTD performance

    Today’s low Today’s high
    ₹ 7.31 ₹ 7.86
    ₹ 7.47
    52 week low 52 week high
    ₹ 6.26 ₹ 13.90
    ₹ 7.47
    Open Price ₹ 7.35
    Prev. Close ₹ 7.57
    Volume (Shares) 39814.00
    Total traded value ₹ 2.97
    Upper Circuit ₹ 8.32
    Lower Circuit ₹ 6.82
    info

    Investment Returns

    Over 1 Month 1.33% Over 3 Months -17.35% Over 6 Months -27.28% Over 1 Year -39.00%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    JHS SVEND. LAB. LTD fundamentals


    • Market cap (Cr) 65.30
    • P/E Ratio (TTM) -33.32
    • Beta 1.47
    • Book Value / share 20.03
    • Return on equity 0.00%
    • EPS (TTM) 0.00
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) -3.57
    info icon alternate text
    • Market cap (Cr) 67.10
    • P/E Ratio (TTM) -33.32
    • Beta 1.42
    • Book Value / share 20.03
    • Return on equity 0.00%
    • EPS (TTM) 0.00
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) -3.57
    info icon alternate text

    JHS SVEND. LAB. LTD Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 32.70
    Operating Expense 36.40
    Net Profit -3.57
    Net Profit Margin (%) -10.91
    Earnings Per Share (EPS) -0.42
    EBITDA -0.89
    Effective Tax Rate (%) -19.79
    Particulars DEC 2025 (Values in Cr)
    Revenue 23.27
    Operating Expense 23.78
    Net Profit 0.79
    Net Profit Margin (%) 3.39
    Earnings Per Share (EPS) 0.09
    EBITDA 2.26
    Effective Tax Rate (%) -887.50
    Particulars SEP 2025 (Values in Cr)
    Revenue 22.28
    Operating Expense 23.43
    Net Profit -0.20
    Net Profit Margin (%) -0.89
    Earnings Per Share (EPS) -0.02
    EBITDA 2.05
    Effective Tax Rate (%) -1800.00
    Particulars JUN 2025 (Values in Cr)
    Revenue 23.45
    Operating Expense 23.83
    Net Profit 1.06
    Net Profit Margin (%) 4.52
    Earnings Per Share (EPS) 0.12
    EBITDA 2.67
    Effective Tax Rate (%) -68.25
    Particulars MAR 2025 (Values in Cr)
    Revenue 25.17
    Operating Expense 32.78
    Net Profit -6.96
    Net Profit Margin (%) -27.65
    Earnings Per Share (EPS) -0.84
    EBITDA -6.82
    Effective Tax Rate (%) 23.09
    Particulars MAR 2026 (Values in Cr)
    Revenue 101.69
    Operating Expense 107.42
    Net Profit -1.92
    Net Profit Margin (%) -1.88
    Earnings Per Share (EPS) -0.22
    EBITDA 6.07
    Effective Tax Rate (%) 16.15
    Particulars MAR 2025 (Values in Cr)
    Revenue 92.00
    Operating Expense 104.52
    Net Profit -19.74
    Net Profit Margin (%) -21.45
    Earnings Per Share (EPS) -2.37
    EBITDA -3.97
    Effective Tax Rate (%) -57.92
    Particulars MAR 2024 (Values in Cr)
    Revenue 70.80
    Operating Expense 78.52
    Net Profit -4.05
    Net Profit Margin (%) -5.72
    Earnings Per Share (EPS) -0.52
    EBITDA 3.38
    Effective Tax Rate (%) -18.42
    Particulars MAR 2023 (Values in Cr)
    Revenue 84.81
    Operating Expense 100.45
    Net Profit -17.52
    Net Profit Margin (%) -20.65
    Earnings Per Share (EPS) -2.23
    EBITDA -16.38
    Effective Tax Rate (%) 23.66
    Particulars MAR 2022 (Values in Cr)
    Revenue 79.91
    Operating Expense 86.13
    Net Profit -2.44
    Net Profit Margin (%) -3.05
    Earnings Per Share (EPS) -0.38
    EBITDA 8.32
    Effective Tax Rate (%) 227.60
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 19.89
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.03
    EBITDA Margin -1.34
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 21.67
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.02
    EBITDA Margin 4.77
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 22.17
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.02
    EBITDA Margin 2.56
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 28.64
    ROE % -2.02
    ROCE % 0.75
    Total Debt to Total Equity 0.04
    EBITDA Margin 9.90
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 29.26
    ROE % 0.73
    ROCE % 1.07
    Total Debt to Total Equity 0.04
    EBITDA Margin 9.24
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 19.93
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.03
    EBITDA Margin -1.34
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 21.72
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.02
    EBITDA Margin 4.77
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 22.22
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.01
    EBITDA Margin 2.56
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 29.24
    ROE % -1.28
    ROCE % 1.25
    Total Debt to Total Equity 0.01
    EBITDA Margin 10.41
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 29.69
    ROE % 1.49
    ROCE % 1.92
    Total Debt to Total Equity 0.01
    EBITDA Margin 9.50
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 19.54
    Total Assets 201.16
    Total Liabilities 201.16
    Total Equity 172.72
    Share Outstanding 8
    Price to Book Ratio 0.56
    Return on Assets (%) -9.81
    Return on Capital (%) -11.1
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 10.36
    Total Assets 197.05
    Total Liabilities 197.05
    Total Equity 169.88
    Share Outstanding 7
    Price to Book Ratio 0.75
    Return on Assets (%) -2.05
    Return on Capital (%) -2.34
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 38.65
    Total Assets 228.22
    Total Liabilities 228.22
    Total Equity 173.84
    Share Outstanding 7
    Price to Book Ratio 0.71
    Return on Assets (%) 1.77
    Return on Capital (%) 2.33
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 6.46
    Total Assets 221.99
    Total Liabilities 221.99
    Total Equity 195.04
    Share Outstanding 6
    Price to Book Ratio 0.70
    Return on Assets (%) -1.82
    Return on Capital (%) -2.07
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 21.14
    Total Assets 227.95
    Total Liabilities 227.95
    Total Equity 197.96
    Share Outstanding 6
    Price to Book Ratio 0.67
    Return on Assets (%) 0.52
    Return on Capital (%) 0.6
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 19.51
    Total Assets 201.56
    Total Liabilities 201.56
    Total Equity 173.13
    Share Outstanding 8
    Price to Book Ratio 0.56
    Return on Assets (%) -9.79
    Return on Capital (%) -11.07
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 10.12
    Total Assets 197.45
    Total Liabilities 197.45
    Total Equity 170.28
    Share Outstanding 7
    Price to Book Ratio 0.75
    Return on Assets (%) -2.05
    Return on Capital (%) -2.33
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 38.61
    Total Assets 215.46
    Total Liabilities 215.46
    Total Equity 174.23
    Share Outstanding 7
    Price to Book Ratio 0.71
    Return on Assets (%) -8.12
    Return on Capital (%) -10.03
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 5.47
    Total Assets 211.08
    Total Liabilities 211.08
    Total Equity 189.76
    Share Outstanding 6
    Price to Book Ratio 0.70
    Return on Assets (%) -1.15
    Return on Capital (%) -1.28
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 16.87
    Total Assets 214.48
    Total Liabilities 214.48
    Total Equity 191.47
    Share Outstanding 6
    Price to Book Ratio 0.67
    Return on Assets (%) 1.28
    Return on Capital (%) 1.44
    Particulars MAR 2025 (Values in Cr)
    Net Income -12.50
    Cash from Operations -4.89
    Cash from Investing -20.25
    Cash from Financing 23.07
    Net change in Cash -2.35
    Free Cash Flow 5.63
    Particulars MAR 2024 (Values in Cr)
    Net Income -3.42
    Cash from Operations -9.30
    Cash from Investing -21.14
    Cash from Financing 2.17
    Net change in Cash -28.14
    Free Cash Flow 22.22
    Particulars MAR 2023 (Values in Cr)
    Net Income -22.95
    Cash from Operations 23.28
    Cash from Investing 9.67
    Cash from Financing -0.63
    Net change in Cash 32.32
    Free Cash Flow 37.62
    Particulars MAR 2022 (Values in Cr)
    Net Income 0.10
    Cash from Operations -8.82
    Cash from Investing -4.69
    Cash from Financing -1.67
    Net change in Cash -15.50
    Free Cash Flow -2.08
    Particulars MAR 2021 (Values in Cr)
    Net Income 0.96
    Cash from Operations 12.80
    Cash from Investing -2.22
    Cash from Financing 10.30
    Net change in Cash 20.11
    Free Cash Flow 21.13
    Particulars MAR 2025 (Values in Cr)
    Net Income -12.50
    Cash from Operations -4.67
    Cash from Investing -20.25
    Cash from Financing 23.07
    Net change in Cash -2.14
    Free Cash Flow 5.85
    Particulars MAR 2024 (Values in Cr)
    Net Income -3.42
    Cash from Operations -8.82
    Cash from Investing -21.82
    Cash from Financing 2.17
    Net change in Cash -28.34
    Free Cash Flow 22.92
    Particulars MAR 2023 (Values in Cr)
    Net Income -22.94
    Cash from Operations 23.25
    Cash from Investing 9.67
    Cash from Financing -0.89
    Net change in Cash 32.03
    Free Cash Flow 37.59
    Particulars MAR 2022 (Values in Cr)
    Net Income 1.92
    Cash from Operations -10.96
    Cash from Investing -0.95
    Cash from Financing 0.01
    Net change in Cash -12.21
    Free Cash Flow -8.35
    Particulars MAR 2021 (Values in Cr)
    Net Income 3.19
    Cash from Operations 16.19
    Cash from Investing -5.58
    Cash from Financing 6.41
    Net change in Cash 16.25
    Free Cash Flow 24.51
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    BRITANNIA INDUSTRIES LTD. 5481.20 52.14 25.85 132024.73 5038.00 6336.95
    NESTLE INDIA LTD. 1494.65 77.77 55.88 288215.50 1085.00 1509.75
    FOODS & INNS LTD. 55.32 14.67 0.71 406.78 45.00 112.00
    HINDUSTAN UNILEVER LTD. 2023.15 43.11 9.75 475357.56 2019.00 2734.31
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    BRITANNIA INDUSTRIES LTD. 5481.20 51.56 28.44 132024.73 5038.00 6336.95
    COLGATE PALMOLIVE LTD. 2135.45 43.22 36.66 58081.17 1781.60 2505.00
    NESTLE INDIA LTD. 1494.65 76.77 54.28 288215.50 1085.00 1509.75
    FOODS & INNS LTD. 55.32 12.99 0.70 406.78 45.00 112.00

    JHS SVEND. LAB. LTD shareholding pattern

    Holding
    63.01%
    33.84%
    3.13%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    JHS SVEND. LAB. LTD Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    7.47 -1.32 redarrow
    red-green-graph indicator
    10 Bearish
    6 Bullish
    • 5 Days 7.40
    • 26 Days 7.60
    • 10 Days 7.40
    • 50 Days 7.90
    • 12 Days 7.40
    • 100 Days 8.40
    • 20 Days 7.50
    • 200 Days 9.70
    7.51 PIVOT
    First Support 7.39 First Resistance 7.70 Second Support 7.20 Second Resistance 7.82 Third Support 7.08 Third Resistance 8.01
    RSI 48.94 ADX 48.04 MACD -0.15 Williams % R -24.00 Commodity Channel Index (CCI) 11.65
    Date 2026-07-28 Week 25468.00 Same Day 22908.00 Month 46590.00
    1 Year 1.48 3 Year 1.01
    Over 1 Month
    1.33% down
    Over 1 Year
    -39.00% down
    Over 3 Months
    -17.35% down
    Over 3 Years
    -28.34% down
    Over 6 Months
    -27.28% down
    Over 5 Years
    -20.26% down

    JHS SVEND. LAB. LTD Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    26 Dec 2011 0.75 Final 28 Dec 2011 Equity shares
    22 Dec 2010 0.5 Final 24 Dec 2010 Equity shares
    10 Sep 2009 0.25 Final 14 Sep 2009 Equity shares
    Dividend date Dividend amount Dividend type Record date Instrument type
    26 Dec 2011 0.75 Final 28 Dec 2011 Equity shares
    22 Dec 2010 0.5 Final 24 Dec 2010 Equity shares
    10 Sep 2009 0.25 Final 14 Sep 2009 Equity shares

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of JHS Svendgaard Laboratories Ltd?

    Answer Field

    JHS Svendgaard Laboratories Ltd share price is for NSE ₹ 7.64 & for BSE ₹ 7.68 as on Jul 29 2026 03:28 PM.

    What is the Market Cap of JHS Svendgaard Laboratories Ltd Share?

    Answer Field

    The market cap of JHS Svendgaard Laboratories Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jul 29 2026 03:28 PM.

    What is the 52 Week High and Low of JHS Svendgaard Laboratories Ltd?

    Answer Field

    The 52 Week High and Low of JHS Svendgaard Laboratories Ltd for NSE is ₹ 13.90 and ₹ 6.26 and for BSE is ₹ 13.83 and ₹ 6.15.

    What is 1 year return for JHS Svendgaard Laboratories Ltd?

    Answer Field

    The 1 year returns on the stock has been -39.00%.

    What is the P/E Ratio of JHS Svendgaard Laboratories Ltd Share?

    Answer Field

    As on Jul 29 2026 03:28 PM the price-to-earnings (PE) ratio for JHS Svendgaard Laboratories Ltd share is -33.32.

    What is the PB ratio of JHS Svendgaard Laboratories Ltd Share?

    Answer Field

    As on Jul 29 2026 03:28 PM, the price-to-book (PB) ratio for JHS Svendgaard Laboratories Ltd share is 20.03.

    How to Buy JHS Svendgaard Laboratories Ltd Share?

    Answer Field

    You can trade in JHS Svendgaard Laboratories Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy JHS Svendgaard Laboratories Ltd Share on Bajaj Broking App?

    Answer Field

    To buy JHS Svendgaard Laboratories Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “JHS Svendgaard Laboratories Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |